Navigation Links
Laureate Announces Manufacturing Agreement with Tolerx
Date:10/21/2008

s design and development to full-scale cGMP production, purification, aseptic filling, testing, validation, analytical services, and regulatory support. Laureate is focused on two active segments of the biopharmaceutical industry: monoclonal antibodies and recombinant protein products. For more information, contact Michael Cavanaugh, Vice President Sales, Marketing, and Business Development at (609) 919-3400, or info@laureatepharma.com or visit http://www.laureatepharma.com.

About Tolerx

Tolerx is a biopharmaceutical company engaged in the discovery and development of novel therapies for immune-mediated diseases. TRX518 is directed to GITR and is in preclinical development for the treatment of cancer and chronic viral diseases. TRX518 is thought to circumvent immune system tolerance by inhibiting the suppressive activity of T regulatory cells and extending the survival of T effector cells, thereby enhancing responses to tumor and viral antigens. Tolerx also has two antibodies in clinical development for the treatment of various autoimmune indications, these are: otelixizumab, an anti-CD3 MAb that is being developed in collaboration with GlaxoSmithKline and MTRX1011A a modified form of TRX1, an anti-CD4 MAb that is being developed in collaboration with Genentech, Inc. In addition to TRX518, Tolerx is also engaged in the preclinical development of other antibodies that may shift or modulate the immune system. For more information, please visit http://www.tolerx.com.


'/>"/>
SOURCE Laureate Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Thomson Scientific Salutes Nobel Laureate Prize Winners, Many of Whom Were Selected as Thomson Scientific Laureates in 2006
2. American Scientists Named as Laureates of the 2008 (24th) Japan Prize
3. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
4. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
5. Laureate Pharma Appoints Gary Swan as Vice President of Operations
6. Laureate Pharma Reports Record Growth for 2007
7. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
8. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
9. Laureate Pharma to Add More Manufacturing Capacity
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... China, Dec. 15 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, ... (Nasdaq: CSKI ), a,leading fully integrated pharmaceutical ... Republic of China ("PRC"), today,announced that the Company ... the 2009,Edition of the National Basic Medical Insurance, ... The 30 medicines treat ...
(Date:12/15/2009)... Company (NYSE: MOS ) plans to issue ... financial tables on Tuesday, January 5, 2010, after the ... Results will be available on Mosaic,s website at ... conference call with presentation slides on Wednesday, January 6, ... begin at 11:00 a.m. Eastern Standard Time (10:00 a.m. ...
(Date:12/15/2009)... , - 45 Patients ... of,Cardiopoietic Cells to Restore Cardiac Function ,, ... biotechnology company specialising,in cell-based therapies for the treatment ... two months ahead of schedule,enrolment in the first ... C-Cure, a,unique stem cell therapy for heart failure. ...
(Date:12/14/2009)... Joins with State Biotech Leaders to Develop ... and Development while Boosting Rhode Island,s Growing ... PROVIDENCE, R.I., Dec. 14 Several ... research, medicine and biotechnology gathered today at ... the importance of medical innovation in Rhode ...
Breaking Biology Technology:China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 2China Sky Medical, Inc. Has 30 Medicines that will Be Included in China's National Insurance Directory 3Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 2Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 3Former Congressman Dick Gephardt Brings National Spotlight to Rhode Island with 'Best and Brightest Forum on Medical Innovation' 4
... Biotech Ltd. (Amex: SVA ), a,leading developer and provider ... three-month and nine-month periods ended,September 30, 2008. , , ... 40% year-over-year to $34.1 million, -- Operating income ... million, -- Net income year-to-date maintained at ...
... based on NVIDIA Tesla GPU Computing technology and integrates dual Intel ... and cooling in a wall-pluggable unit. , ... San ... the new flagship of its personal supercomputing and technical workstation line, ...
... the first healthcare group in Southeast Asia to offer the In-Space ... ... Singapore (PRWEB) November 18, 2008 -- Singapore,s ParkwayHealth is the ... interspinous distraction device, a revolutionary spinal procedure ., , , ...
Other Biology Technology:Sinovac Reports Third Quarter 2008 Unaudited Financial Results 2Sinovac Reports Third Quarter 2008 Unaudited Financial Results 3Sinovac Reports Third Quarter 2008 Unaudited Financial Results 4Sinovac Reports Third Quarter 2008 Unaudited Financial Results 5Sinovac Reports Third Quarter 2008 Unaudited Financial Results 6Sinovac Reports Third Quarter 2008 Unaudited Financial Results 7Sinovac Reports Third Quarter 2008 Unaudited Financial Results 8Sinovac Reports Third Quarter 2008 Unaudited Financial Results 9Sinovac Reports Third Quarter 2008 Unaudited Financial Results 10Sinovac Reports Third Quarter 2008 Unaudited Financial Results 11Sinovac Reports Third Quarter 2008 Unaudited Financial Results 12Sinovac Reports Third Quarter 2008 Unaudited Financial Results 13Sinovac Reports Third Quarter 2008 Unaudited Financial Results 14Sinovac Reports Third Quarter 2008 Unaudited Financial Results 15Sinovac Reports Third Quarter 2008 Unaudited Financial Results 16Penguin Computing Announces Niveus HTX Personal Supercomputer 2Singapore Medicine - Singapore Doctors Use Hi-Tech Implant to Add Space to Narrowed Spinal Canals 2Singapore Medicine - Singapore Doctors Use Hi-Tech Implant to Add Space to Narrowed Spinal Canals 3Singapore Medicine - Singapore Doctors Use Hi-Tech Implant to Add Space to Narrowed Spinal Canals 4
(Date:12/14/2009)... diseases can be transmitted by sneezing, touching, or ... face, a habit that may have driven the dinosaurs ... , Jacqueline Upcroft, a member of f1000 Biology, highlights ... published in PLoS One. This led them to deduce ... diseased jaw bones seen in many tyrannosaurid fossils. , ...
(Date:12/14/2009)... date of the proteins in a species of salamander ... how similar regeneration could be induced in humans. ... University-Purdue University Indianapolis and colleagues investigated over three hundred ... of salamander that has the unique natural ability to ... hope that this knowledge will contribute to a better ...
(Date:12/14/2009)... of researchers from the Astrobiology Centre (INTA-CSIC) has shown ... to the formation of the most basic biological molecules ... order to carry out this study, published in the ... the chemical conditions of the early Earth. , "We ... ammoniac solutions it produces hydrogen cyanide, a substance that ...
Breaking Biology News(10 mins):IUPUI researchers tackle protein mechanisms behind limb regeneration 2Prussian blue linked to the origin of life 2World forest observatory needed to monitor vital role of forests in climate deal 10930 1World forest observatory needed to monitor vital role of forests in climate deal 10930 2CT Scan Patients May Get Unnecessary Imaging 62284 1CT Scan Patients May Get Unnecessary Imaging 62284 2TheBody com Launches My Health Tracker Enabling HIV Positive Patients to Track Lab Results Medications and Supplements 62279 1TheBody com Launches My Health Tracker Enabling HIV Positive Patients to Track Lab Results Medications and Supplements 62279 2
... of Virginia Beach, a graduate student in Virginia ... first-ever Rachel Carson Award for Scientific Excellence from ... a biologist at the agency,s White Sulphur Springs ... employees who demonstrate superior scientific involvement and application ...
... Ga. - Veterans exposed to Agent Orange are at ... report. , A study of 1,495 veterans who underwent ... the 206 exposed to Agent Orange had nearly a ... the fact that their cancer seemed relatively nonaggressive at ...
... ORLEANS --- Eating just one and a half servings of ... according to new University of Michigan research reported at the ... the study, healthy adults who ate a cup and a ... five different anthocyanins the natural antioxidants that give cherries ...
Other Biology News:Agent Orange exposure increases veterans' risk of aggressive recurrence of prostate cancer 2Agent Orange exposure increases veterans' risk of aggressive recurrence of prostate cancer 3New human study reinforces antioxidant benefits of tart cherries 2
The strip cap tool is a used for properly seating 8- and 12-cap strips in microplates or strip tubes. A grooved channel on one side is designed to seat domed caps, while the flat edge on the opposite...
Experion Pro260 chips are the microfluidic chips used to perform protein analysis with the Experion automated electrophoresis system. Each chip has the capacity to run 10 protein samples. Supplied as...
...
...
Biology Products: